Anticonvulsants Flashcards

(31 cards)

1
Q

Partial vs Generalized seizure

A

Partial - focal/ localised onset, where they [can be] still aware (or not)
Generalised - affecting both hemispheres, with characteristic features of:
- Absence (lapse of awareness)
- Myoclonic (sudden massive jerk - Upper limbs > )
- Atonic
- Tonic - clonic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define Seizure

A

Clinical manifestation of an abn & excessive paroxysmal discharge of cerebral neurones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define Epilepsy

A

Chronic condition with recurrent, unprovoked seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

3 goals of anticonvulsant therapy:

A

1 - seizure free/ significant reduction in seizures
2 - Minimize drug effects
3 - Maintain/ restore QoL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Requirements to start AC therapy at first seizure

A
  • Structural brain lesion
  • Abnormal neuro exam
  • Status epilepticus at presentation
  • Strong family Hx
  • Epileptiform abnormal on EEG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which Anti-convulsant drug has the best side effects profile and is most effective

A

HAH! TRICK QUESTION! (sorry liv). NO single ACD is most effective / best tolerated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How to select ACD

A

o Type of seizure
o Potential for drug interaction
o Comorbid disease / SE profile
o Pregnancy risk
o Cost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do you go about initiating ACD in terms of dosage

A

Start low and increase gradually to build a therapeutic dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How many different agents should be used:

A

MONOTHERAPY IS THE GOAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

If trial of one drug is failing what are you next steps:

A

check adherence, drug concentration at therapeutic range – if no cause found then gradually withdraw – try another monotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Problems with multimodal AC therapy (multiple drugs)

A

higher toxicity risk
interaction
jeopardises adherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When to stop ACT

A

Consider if seizure free >2 yrs - Especially if normal EEG, no structural lesion, normal intelligence
Taper off very slowly (3/12)
Patient must understand risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

2 main mechanisms of actions of anticonvulsants:

A

1 - Reduce high frequency neuronal firing by modifying neurotransmitter activity [ie. benzos; valproate]
o Increase GABA activity
o Reduce excitatory glutamate
2- Modify activity of ion channels [ie. carba.; phenytoin etc.]
o Voltage gate Na channels
o Ca channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why therapeutic drug monitoring is important in epilepsy

A

High variability in PK/PD (efficacy and toxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When to start therapeutic drug monitoring

A

Poor seizure control
Features of toxicity
Possible interacting drug co-administered
Assess adherence
Guide dose adjustments when interacting drug added to or removed from regimen or during pregnancy
NOT if seizures well controlled & no toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How to do therapeutic drug monitoring

A

Wait until steady state achieved (4-5 half lives) before starting monitoring
Therapeutic range = guide only
Dose determination depends on ind response & adverse effects
Most have narrow therapeutic index

17
Q

What is status epilepticus

A

A seizure or cluster of seizures lasting 30 minutes > without intervening periods of consciousness. It is a medical emergency because death and permanent brain damage risk increase with length of attack.

18
Q

Management of status epilepticus

A

1 - abort the seizure - IV benzo [Lora/dia/clonazepam], if no IV access can use buccal or IM [lorazepam/clonazepam only], or PR [diazepam]
2 - Airway maintenance after seizure aborted
3 - Prevent further seizures - IV infusion phenytoin loading dose followed by maintenance doses (phenobarb preferred in children)

19
Q

If you cannot control seizures in S.Epilepticus

A

Intubate and Thiopental/Propofol

19
Q

If you cannot control seizures in S.Epilepticus

A

Intubate and Thiopental/Propofol infusion

20
Q

Anticonvulsants in pregnancy

A

AVOID Sodium valproate, Carbamazepine is lowest risk
* Folate supplementation essential- preferably before conception
* Pregnancy reduces drug levels in 2nd and 3rd trimesters, adjust dose according to levels

21
Q

BONUSSSSS - Drugs possible for … type of seizures:
1 - Tonic-clonic
2- Absence
3- Myoclonic
4- Focal seizures

A

Tonic-clonic: Carb; Phenytoin; Phenobarbital; Lamotrigine; Valproate
Absence: Ethosuximide; Valproate; (Lamotrigine – off label) +++
Myoclonic: Clonazepam; Valproate
Focal seizures: Carb; Gabapentin; Phenytoin; Phenobarbital; Lamotrigine; Valproate; +++

22
Q

Phenobarbital (barbiturate)
Indications
MOA
PK
CI’s

A

Indications: Epilepsy except for absence or myoclonic; Status epilepticus
MOA: GABA receptor mediation
PK: Good oral bioavailibility (70%-90%), Metab. in liver, Excreted in urine, steady state in 10-16 days
CI’s: Severe hepatic/renal impairment, Porphyria

23
Q

Phenobarbital (barbiturate)
Cautions
Adverse effects
Drug Interactions

A

Cautions: DM, Hyperthy., asthma (other resp. diseases), geriatric things (confusion, depression), pregnancy (not safe but risks < seizures)
Adverse effects: drowsiness (decreases over time), CNS (ataxia, nystag., dizzy), derm (hypersens. and photosensitivity), Vitamin D def., withdrawal and dependence
Drug Interactions: Induces!!!!! hepatic microsomal enzymes therefore Hepatic metab. agents [warfarin, COCs, Corticosteroids, tetracyclines, digoxin, beta blockers]; ARVs (reduces levels);

24
Phenytoin Indications MOA PK CI's
Indications: Epilepsy except absence or myoclonic , Status epilepticus MOA: Prolongs inactivation of voltage sensitive Na Channels PK: variable oral bioavail.; protein bound; Metab. in liver but it is saturable [inc. doses small]; renal excretion; steady in 5-10 days CI's: Impaired cardiac func, Porphyria
25
Phenytoin Cautions Adverse effects Drug Interactions
Cautions: liv and hep. compromise; Preg. [not safe have to give folic acid and prophylactic vit. K to mother as well as monitor freq.] Adverse effects: CVS arrythmias; CNS cerebellar Sx, skin rashes NB: gum hypertrophy, hirsuitism, decreased bone density, folic acid depletion problems associated: strong inducer of CYP and UGT, reduces effectiveness of most forms of hormonal contraceptives
26
Phenytoin drug interactions
↑ phenytoin levels: Acute alcohol intake Fluconazole Fluoxetine Isoniazid Diazepam ↓ phenytoin levels Chronic alcohol abuse Folic acid Rifampicin Theophylline Ca supplements & antacids (reduced absorption, take 1-3h apart) Other anti-epileptics: unpredictable, must be monitored Lamotrigine: induced lam met ARVS: avoid concurrent use Lithium: toxicity sx but normal range COCs Warfarin: change to anticoag efficacy
27
Carbamazepine Indications Mechanism PK CI's Adverse effects Drug interactions
Indications: Epilepsy except absence or myoclonic or atonic, Management of pain esp neuralgia Mechanism: Prolongs inactivation of voltage sensitive Na Channels and potentiates postsynaptic actions of GABA PK: Slow and variable absorp.; enhanced with food; metab. by liver exc. renal; AUTOINDUCTION CI's: AV block, porphyria Adverse Effects - Drowsiness, vertigo, ataxia, diplopia and blurred vision Heamatological toxicity – aplastic anaemia, agranulocytosis; Hypersensitivity Extra: before initiation: FBC, renal & LFTS before Monitor serum Na (SIADH) Take with food
28
Valproate Indications Drug interactions Mechanism Adverse effects
AVOID IN WOMAN OF CHILDBEARING AGE
29
what is the metabolism of phenytoin
saturable, zero-order increased dose means plasma conc rises exponentially (not linearly)
30
Why is phenytoin monitoring a bit tricky?
Highly protein-bound narrow therapeutic window nonlinear PK